Announcements

Scott Alderman will be the new Associate Chief Operating Officer and Maureen Maughan has assumed the role of Director of GMP Manufacturing and Operations.

Wilton B. Williams, PhD, associate professor in surgery and co-director of the Duke Human Vaccine Institute (DHVI) Training and Mentoring Program (DTMP), was awarded the R37 meritorious award on June 3, 2024, from the National Institute of Allergy and Infectious Diseases (NIAID).

The Duke Human Vaccine Institute is pleased to announce that Kshitij Wagh, PhD, has been recruited to a faculty position in the Duke Human Vaccine Institute (DHVI), effective May 15, 2024.

Duke Human Vaccine Institute (DHVI) is pleased to announce that Daniel Wrapp, PhD, has been promoted to the faculty position of assistant professor in the Department of Medicine at Duke, effective June 1, 2024.

The Duke Human Vaccine Institute (DHVI) Accessioning Unit and Biorepository (AUB) became an American Association of Laboratory Accreditation (A2LA) accredited biobank under the International Organization of Standardization (ISO) 20387:2018 standard in January 2024. DHVI’s AUB became one of only ten A2LA ISO 20387 accredited biobanks in the world.